Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Vash1 | Rat | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of VASH1 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the more ... | CTD | PMID:19414516 | Vash1 | Rat | 1,2-dichloroethane | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of VASH1 mRNA | CTD | PMID:28960355 | Vash1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Vash1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of VASH1 mRNA | CTD | PMID:22206623 | Vash1 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Vash1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of VASH1 mRNA | CTD | PMID:17555576 | Vash1 | Rat | 17beta-estradiol | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of VASH1 mRNA | CTD | PMID:20660070 | Vash1 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VASH1 mRNA | CTD | PMID:32741896 | Vash1 | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VASH1 mRNA | CTD | PMID:32741896 | Vash1 | Rat | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of VASH1 mRNA | CTD | PMID:36804509 | Vash1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Vash1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of VASH1 mRNA | CTD | PMID:24680724 | Vash1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VASH1 mRNA | CTD | PMID:33387578 | Vash1 | Rat | 2-methylcholine | affects expression | ISO | VASH1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of VASH1 mRNA | CTD | PMID:21179406 | Vash1 | Rat | 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of VASH1 mRNA] | CTD | PMID:19414516 | Vash1 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VASH1 mRNA | CTD | PMID:20188158 | Vash1 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of VASH1 mRNA | CTD | PMID:28973697 | Vash1 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | VASH1 (Homo sapiens) | 6480464 | Decitabine affects the expression of VASH1 mRNA | CTD | PMID:23300844 | Vash1 | Rat | acrylamide | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of VASH1 mRNA | CTD | PMID:32763439 | Vash1 | Rat | aflatoxin B1 | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of VASH1 mRNA | CTD | PMID:21641981 | Vash1 | Rat | arsane | affects expression | ISO | VASH1 (Homo sapiens) | 6480464 | Arsenic affects the expression of VASH1 mRNA | CTD | PMID:18414638 | Vash1 | Rat | arsane | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Vash1 | Rat | arsenic atom | affects expression | ISO | VASH1 (Homo sapiens) | 6480464 | Arsenic affects the expression of VASH1 mRNA | CTD | PMID:18414638 | Vash1 | Rat | arsenic atom | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Vash1 | Rat | arsenous acid | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of VASH1 mRNA | CTD | PMID:22521957 | Vash1 | Rat | benzo[a]pyrene | multiple interactions | ISO | Vash1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Vash1 | Rat | benzo[a]pyrene | decreases methylation | ISO | VASH1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of VASH1 exon | CTD | PMID:27901495 | Vash1 | Rat | benzo[a]pyrene | affects methylation | ISO | VASH1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of VASH1 promoter | CTD | PMID:27901495 | Vash1 | Rat | benzo[a]pyrene | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of VASH1 mRNA | CTD | PMID:32417428 | Vash1 | Rat | benzo[b]fluoranthene | multiple interactions | ISO | Vash1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Vash1 | Rat | Benzo[k]fluoranthene | decreases expression | ISO | Vash1 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in decreased expression of VASH1 mRNA | CTD | PMID:26377693 | Vash1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VASH1 mRNA | CTD | PMID:25181051|PMID:30816183 | Vash1 | Rat | bisphenol A | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of VASH1 mRNA | CTD | PMID:32156529 | Vash1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of VASH1 mRNA | CTD | PMID:34947998 | Vash1 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Vash1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of VASH1 intron | CTD | PMID:28392331 | Vash1 | Rat | carbon nanotube | decreases expression | ISO | Vash1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of VASH1 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Vash1 | Rat | chrysene | multiple interactions | ISO | Vash1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Vash1 | Rat | cisplatin | affects expression | ISO | VASH1 (Homo sapiens) | 6480464 | Cisplatin affects the expression of VASH1 mRNA | CTD | PMID:23300844 | Vash1 | Rat | clobetasol | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of VASH1 mRNA | CTD | PMID:27462272 | Vash1 | Rat | diarsenic trioxide | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of VASH1 mRNA | CTD | PMID:22521957 | Vash1 | Rat | diazinon | decreases methylation | ISO | VASH1 (Homo sapiens) | 6480464 | Diazinon results in decreased methylation of VASH1 gene | CTD | PMID:22964155 | Vash1 | Rat | dorsomorphin | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Vash1 | Rat | doxorubicin | decreases expression | ISO | Vash1 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of VASH1 mRNA | CTD | PMID:39631538 | Vash1 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of VASH1 mRNA | CTD | PMID:29391264 | Vash1 | Rat | entinostat | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of VASH1 mRNA | CTD | PMID:26272509|PMID:27188386 | Vash1 | Rat | entinostat | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Vash1 | Rat | ethanol | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | Ethanol results in increased expression of VASH1 mRNA | CTD | PMID:30319688 | Vash1 | Rat | finasteride | decreases expression | EXP | | 6480464 | Finasteride results in decreased expression of VASH1 mRNA | CTD | PMID:24136188 | Vash1 | Rat | folic acid | multiple interactions | ISO | Vash1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of VASH1 mRNA | CTD | PMID:22206623 | Vash1 | Rat | folic acid | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of VASH1 mRNA | CTD | PMID:21867686 | Vash1 | Rat | folic acid | decreases expression | ISO | Vash1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of VASH1 mRNA | CTD | PMID:25629700 | Vash1 | Rat | fonofos | increases methylation | ISO | VASH1 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of VASH1 promoter | CTD | PMID:22847954 | Vash1 | Rat | FR900359 | affects phosphorylation | ISO | VASH1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of VASH1 protein | CTD | PMID:37730182 | Vash1 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of VASH1 mRNA | CTD | PMID:33387578 | Vash1 | Rat | lipopolysaccharide | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of VASH1 mRNA | CTD | PMID:35811015 | Vash1 | Rat | lipopolysaccharide | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of VASH1 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Vash1 | Rat | manganese atom | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Vash1 | Rat | manganese(0) | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Vash1 | Rat | manganese(II) chloride | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Vash1 | Rat | mercury dibromide | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of VASH1 mRNA | CTD | PMID:26272509 | Vash1 | Rat | mercury dibromide | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Vash1 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of VASH1 gene | CTD | PMID:35440735 | Vash1 | Rat | methylphenidate | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | Methylphenidate results in increased expression of VASH1 mRNA | CTD | PMID:22470460 | Vash1 | Rat | miconazole | increases expression | ISO | Vash1 (Mus musculus) | 6480464 | Miconazole results in increased expression of VASH1 mRNA | CTD | PMID:27462272 | Vash1 | Rat | paracetamol | affects expression | ISO | Vash1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of VASH1 mRNA | CTD | PMID:17562736 | Vash1 | Rat | parathion | increases methylation | ISO | VASH1 (Homo sapiens) | 6480464 | Parathion results in increased methylation of VASH1 promoter | CTD | PMID:22847954 | Vash1 | Rat | phenylmercury acetate | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of VASH1 mRNA | CTD | PMID:26272509 | Vash1 | Rat | phenylmercury acetate | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Vash1 | Rat | progesterone | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of VASH1 mRNA | CTD | PMID:20660070 | Vash1 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of VASH1 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Vash1 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine results in decreased expression of VASH1 mRNA | CTD | PMID:35811015 | Vash1 | Rat | SB 431542 | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Vash1 | Rat | sodium arsenite | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Vash1 | Rat | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of VASH1 mRNA | CTD | PMID:19281266 | Vash1 | Rat | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of VASH1 mRNA | CTD | PMID:24136188 | Vash1 | Rat | tamoxifen | affects expression | ISO | Vash1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of VASH1 mRNA | CTD | PMID:17555576 | Vash1 | Rat | terbufos | increases methylation | ISO | VASH1 (Homo sapiens) | 6480464 | terbufos results in increased methylation of VASH1 promoter | CTD | PMID:22847954 | Vash1 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VASH1 mRNA | CTD | PMID:32741896 | Vash1 | Rat | tetraphene | multiple interactions | ISO | Vash1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Vash1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of VASH1 mRNA | CTD | PMID:34492290 | Vash1 | Rat | titanium dioxide | decreases methylation | ISO | Vash1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of VASH1 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Vash1 | Rat | trichostatin A | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of VASH1 mRNA | CTD | PMID:24935251 | Vash1 | Rat | trovafloxacin | decreases expression | ISO | Vash1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of VASH1 mRNA | CTD | PMID:35537566 | Vash1 | Rat | valproic acid | decreases expression | ISO | VASH1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of VASH1 mRNA | CTD | PMID:23179753|PMID:26272509 | Vash1 | Rat | valproic acid | multiple interactions | ISO | VASH1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Vash1 | Rat | zoledronic acid | increases expression | ISO | VASH1 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of VASH1 mRNA | CTD | PMID:20977926 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















